Doug Cole

Managing Partner · Flagship Ventures · Cambridge, United States

Decision maker

Email

Verified, deliverable email

Managing Partner at Flagship Pioneering

Stages: Series A
Sectors: Health tech
Cheque size: €92k–€4.6M
Location: Cambridge, United States
Freshness: Verified today

Notable investments

Harbinger HealthSeries B · $140M · 2023
Empress TherapeuticsSeries Unknown · $50M · 2023
Vesalius TherapeuticsSeries A · $75M · 2022
Repertoire Immune MedicinesSeries B · $190M · 2021
Sigilon TherapeuticsSeries B · $80M · 2020
Foghorn TherapeuticsSeries Unknown · $50M · 2018
YourBio HealthSeries C · $10M · 2016
Denali TherapeuticsSeries B · $130M · 2016

Frequently co-invests with

Noubar AfeyanFlagship Ventures2×Alan CranePolaris PartnersKatie ElliasT1D FundRobert NelsenARCH Venture PartnersStacie WeningerF-Prime Capital Partners

Background

General PartnerFlagship Ventures
Program ExecutiveVertex Pharmaceuticals
Medical DirectorCytotherapeutics, Inc.
Assistant in NeurologyMassachusetts General Hospital
Instructor in NeurologyHarvard Medical School
Fellow in NeurologyMassachusetts General Hospital
Resident in NeurologyMassachusetts General Hospital
Intern in Internal Medicine, Osler Medical ServiceJohns Hopkins Hospital

Related lists

Health tech investors Series A Health tech in United States

Similar investors

Richard WellsManaging Director, Insight Partners

Ralph (Chris) ChristoffersenPartner, Morgenthaler Ventures

Reinhard VogtVenture Partner, Dynamk Capital

Raj ParekhGeneral Partner, Advent Life Sciences

Blake PateAnalyst, Bios Partners

Richard LimManaging Partner, Cure Ventures

Every contact is a verified, deliverable email. How Mintround verifies contacts.

Are you Doug Cole? Request removal of this listing.